Non-Hodgkin's lymphoma of the gastrointestinal tract: an analysis of clinical and pathologic features affecting outcome.

A. F. List, J. P. Greer, J. C. Cousar, R. S. Stein, D. H. Johnson, V. H. Reynolds, F. A. Greco, J. M. Flexner, K. R. Hande

Research output: Contribution to journalArticle

82 Citations (Scopus)

Abstract

Clinical and histopathologic data from 87 patients with primary non-Hodgkin's lymphoma of the gastrointestinal (GI) tract diagnosed between 1974 and 1984 were reviewed. B-cell lymphomas of intermediate- or high-grade histology constituted 78% of lesions. Stage of disease varied with histologic grade, with a preponderance of advanced disease (stages IIIE and IV) in patients with low-grade lymphoma (15 of 21) (71%), compared with higher grade lesions (38%, P = .01). Among patients with nonlocalized (stages IIE through IV) lymphoma of intermediate- or high-grade histology, surgical resection of the primary focus afforded a higher rate of complete remission (CR) (70% v 50%) and sustained CR (61% v 21%, P = .04) after cytotoxic therapy compared with the nonresected cohort. The median survival in the resected group was 51 months + compared with 13 months in the nonresected patients (P = .012). Differences in outcome were attributable to a high risk of treatment-related complications (perforation and/or hemorrhage) (43% v 0%, P = .001) and local relapse (29% v 4%, P = .05) in nonresected individuals. Life-threatening local complications were not observed in patients with low-grade lymphoma managed solely with medical therapy. Histologic findings from surgically staged patients identified presence of extravisceral disease and intermediate- or high-grade tumor histology as features predictive of transmural invasion, enabling potential identification of patients who might be optimally managed by resection of the primary GI focus before initiation of cytotoxic therapy.

Original languageEnglish (US)
Pages (from-to)1125-1133
Number of pages9
JournalJournal of clinical oncology : official journal of the American Society of Clinical Oncology
Volume6
Issue number7
StatePublished - Jul 1988

Fingerprint

Non-Hodgkin's Lymphoma
Gastrointestinal Tract
Histology
B-Cell Lymphoma
Therapeutics
Lymphoma
Hemorrhage
Recurrence
Survival
Neoplasms

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Non-Hodgkin's lymphoma of the gastrointestinal tract : an analysis of clinical and pathologic features affecting outcome. / List, A. F.; Greer, J. P.; Cousar, J. C.; Stein, R. S.; Johnson, D. H.; Reynolds, V. H.; Greco, F. A.; Flexner, J. M.; Hande, K. R.

In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 6, No. 7, 07.1988, p. 1125-1133.

Research output: Contribution to journalArticle

List, A. F. ; Greer, J. P. ; Cousar, J. C. ; Stein, R. S. ; Johnson, D. H. ; Reynolds, V. H. ; Greco, F. A. ; Flexner, J. M. ; Hande, K. R. / Non-Hodgkin's lymphoma of the gastrointestinal tract : an analysis of clinical and pathologic features affecting outcome. In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1988 ; Vol. 6, No. 7. pp. 1125-1133.
@article{4b8b82ded5c14f0284a81b8a44671e1e,
title = "Non-Hodgkin's lymphoma of the gastrointestinal tract: an analysis of clinical and pathologic features affecting outcome.",
abstract = "Clinical and histopathologic data from 87 patients with primary non-Hodgkin's lymphoma of the gastrointestinal (GI) tract diagnosed between 1974 and 1984 were reviewed. B-cell lymphomas of intermediate- or high-grade histology constituted 78{\%} of lesions. Stage of disease varied with histologic grade, with a preponderance of advanced disease (stages IIIE and IV) in patients with low-grade lymphoma (15 of 21) (71{\%}), compared with higher grade lesions (38{\%}, P = .01). Among patients with nonlocalized (stages IIE through IV) lymphoma of intermediate- or high-grade histology, surgical resection of the primary focus afforded a higher rate of complete remission (CR) (70{\%} v 50{\%}) and sustained CR (61{\%} v 21{\%}, P = .04) after cytotoxic therapy compared with the nonresected cohort. The median survival in the resected group was 51 months + compared with 13 months in the nonresected patients (P = .012). Differences in outcome were attributable to a high risk of treatment-related complications (perforation and/or hemorrhage) (43{\%} v 0{\%}, P = .001) and local relapse (29{\%} v 4{\%}, P = .05) in nonresected individuals. Life-threatening local complications were not observed in patients with low-grade lymphoma managed solely with medical therapy. Histologic findings from surgically staged patients identified presence of extravisceral disease and intermediate- or high-grade tumor histology as features predictive of transmural invasion, enabling potential identification of patients who might be optimally managed by resection of the primary GI focus before initiation of cytotoxic therapy.",
author = "List, {A. F.} and Greer, {J. P.} and Cousar, {J. C.} and Stein, {R. S.} and Johnson, {D. H.} and Reynolds, {V. H.} and Greco, {F. A.} and Flexner, {J. M.} and Hande, {K. R.}",
year = "1988",
month = "7",
language = "English (US)",
volume = "6",
pages = "1125--1133",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "7",

}

TY - JOUR

T1 - Non-Hodgkin's lymphoma of the gastrointestinal tract

T2 - an analysis of clinical and pathologic features affecting outcome.

AU - List, A. F.

AU - Greer, J. P.

AU - Cousar, J. C.

AU - Stein, R. S.

AU - Johnson, D. H.

AU - Reynolds, V. H.

AU - Greco, F. A.

AU - Flexner, J. M.

AU - Hande, K. R.

PY - 1988/7

Y1 - 1988/7

N2 - Clinical and histopathologic data from 87 patients with primary non-Hodgkin's lymphoma of the gastrointestinal (GI) tract diagnosed between 1974 and 1984 were reviewed. B-cell lymphomas of intermediate- or high-grade histology constituted 78% of lesions. Stage of disease varied with histologic grade, with a preponderance of advanced disease (stages IIIE and IV) in patients with low-grade lymphoma (15 of 21) (71%), compared with higher grade lesions (38%, P = .01). Among patients with nonlocalized (stages IIE through IV) lymphoma of intermediate- or high-grade histology, surgical resection of the primary focus afforded a higher rate of complete remission (CR) (70% v 50%) and sustained CR (61% v 21%, P = .04) after cytotoxic therapy compared with the nonresected cohort. The median survival in the resected group was 51 months + compared with 13 months in the nonresected patients (P = .012). Differences in outcome were attributable to a high risk of treatment-related complications (perforation and/or hemorrhage) (43% v 0%, P = .001) and local relapse (29% v 4%, P = .05) in nonresected individuals. Life-threatening local complications were not observed in patients with low-grade lymphoma managed solely with medical therapy. Histologic findings from surgically staged patients identified presence of extravisceral disease and intermediate- or high-grade tumor histology as features predictive of transmural invasion, enabling potential identification of patients who might be optimally managed by resection of the primary GI focus before initiation of cytotoxic therapy.

AB - Clinical and histopathologic data from 87 patients with primary non-Hodgkin's lymphoma of the gastrointestinal (GI) tract diagnosed between 1974 and 1984 were reviewed. B-cell lymphomas of intermediate- or high-grade histology constituted 78% of lesions. Stage of disease varied with histologic grade, with a preponderance of advanced disease (stages IIIE and IV) in patients with low-grade lymphoma (15 of 21) (71%), compared with higher grade lesions (38%, P = .01). Among patients with nonlocalized (stages IIE through IV) lymphoma of intermediate- or high-grade histology, surgical resection of the primary focus afforded a higher rate of complete remission (CR) (70% v 50%) and sustained CR (61% v 21%, P = .04) after cytotoxic therapy compared with the nonresected cohort. The median survival in the resected group was 51 months + compared with 13 months in the nonresected patients (P = .012). Differences in outcome were attributable to a high risk of treatment-related complications (perforation and/or hemorrhage) (43% v 0%, P = .001) and local relapse (29% v 4%, P = .05) in nonresected individuals. Life-threatening local complications were not observed in patients with low-grade lymphoma managed solely with medical therapy. Histologic findings from surgically staged patients identified presence of extravisceral disease and intermediate- or high-grade tumor histology as features predictive of transmural invasion, enabling potential identification of patients who might be optimally managed by resection of the primary GI focus before initiation of cytotoxic therapy.

UR - http://www.scopus.com/inward/record.url?scp=0024043741&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024043741&partnerID=8YFLogxK

M3 - Article

C2 - 3392561

AN - SCOPUS:0024043741

VL - 6

SP - 1125

EP - 1133

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 7

ER -